Tech Company Financing Transactions

Imagene AI Funding Round

On 5/3/2022, Imagene AI received $21.5 million in funding from Blumberg Capital and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

20 Lincoln St.
Tel Aviv, Undisclosed
Israel

Phone

Undisclosed

Website

www.imagene-ai.com

Email Address

[email protected]

Overview

Imagene AI was founded in 2020 with a clear mission, to assist cancer patients in receiving the optimal treatment medicine can offer. We are leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dean Bitan

        

Chief Medical Officer

Nir Peled

        

Chief Scientific Officer

Nurit Paz-Yaacov

        

Chief Technical Officer

Shahar Porat

        

Co-Founder

Jonathan Zalach

        

Vice President

William Brown

        

VP - Human Resources

Efrat Rahat

        

Browse more venture capital transactions:

Prev: 5/3/2022: Dianthus Therapeutic venture capital transaction
Next: 5/3/2022: Lumos App venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary